Together, these results suggest that while Pbx1 functions as an early target of MNX1 in preleukemic cells, Pbxip1 and Pbx4 act as secondary (indirect) targets whose altered expression arises with MNX1 leukemia progression. Here, PBX4 is linked to leukemia.